CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 42 filers reported holding CIDARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,068,936 | -16.6% | 1,134,511 | 0.0% | 0.31% | -3.4% |
Q2 2023 | $1,281,997 | -11.0% | 1,134,511 | 0.0% | 0.32% | -13.3% |
Q1 2023 | $1,440,829 | +67.9% | 1,134,511 | 0.0% | 0.37% | +59.3% |
Q4 2022 | $858,031 | +20.5% | 1,134,511 | 0.0% | 0.23% | +69.9% |
Q3 2022 | $712,000 | +28.5% | 1,134,511 | 0.0% | 0.14% | -0.7% |
Q2 2022 | $554,000 | -41.4% | 1,134,511 | 0.0% | 0.14% | -33.5% |
Q1 2022 | $945,000 | -34.4% | 1,134,511 | 0.0% | 0.21% | -23.7% |
Q4 2021 | $1,441,000 | -43.3% | 1,134,511 | 0.0% | 0.27% | -47.7% |
Q3 2021 | $2,541,000 | -37.3% | 1,134,511 | -43.5% | 0.52% | -49.4% |
Q2 2021 | $4,053,000 | -24.1% | 2,006,511 | 0.0% | 1.02% | +6.1% |
Q1 2021 | $5,337,000 | +33.0% | 2,006,511 | 0.0% | 0.96% | -28.9% |
Q4 2020 | $4,013,000 | -29.8% | 2,006,511 | 0.0% | 1.35% | -10.1% |
Q3 2020 | $5,719,000 | -22.8% | 2,006,511 | 0.0% | 1.50% | -7.2% |
Q2 2020 | $7,404,000 | +48.8% | 2,006,511 | 0.0% | 1.62% | +5.2% |
Q1 2020 | $4,976,000 | -35.4% | 2,006,511 | 0.0% | 1.54% | -7.1% |
Q4 2019 | $7,705,000 | – | 2,006,511 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |